Glaxo to Hire Hundreds in China as Drug Access to Widen

GlaxoSmithKline Plc is adding new products in China and hiring “a few hundred” more salespeople to promote them, betting that health-care reforms will widen access to drugs and make up for state-mandated price cuts.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.